Owlet, Inc.

NYSE:OWLT

Medical - Devices

Healthcare
$3.67 +9.76%

+$0.46 today

Market cap
$107.24M
Beta
1.86
P/E (TTM)
-0.4
EPS (TTM)
-$12.67
52W Low $4.19High $16.94

Volume 0.64M

Average 0.24M

OWLT Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Owlet, Inc.NYSE: OWLT

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue grows, but more slowly than its trailing trend

Q1 FY2026 revenue of $22.46M rose 6.4% year over year, behind the +26.8% change in trailing-twelve-month revenue. Sequentially, it fell 15.4% from the prior quarter. Over 3 fiscal years it compounded at +15.2% a year.

Context

  • Revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 3 analysts of $112.81M (+6.7%) for the fiscal year ending Dec 2026, a slowdown from the +35.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$22.46M-15.4% QoQ
Last fiscal yearDec 2025
$105.71M+35.4% YoY
LTMMar 2026
$107.06M+26.8% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.4%+21.7%+15.3 pp
1 year+35.4%+6.7%-28.7 pp
3-year CAGR+15.2%+15.3%+0.1 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
105.71M USD
Year-over-year change
+35.4%
4-year CAGR
+8.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How OWLT compares with its peers on the latest reported figures

  • OWLT's LTM Mar 2026 revenue of $107.06M is the 2nd highest of the 10 companies compared; the peer median is $5.13M.
  • Its year-over-year change of +26.8% is the highest of 8, against a peer median of +1.1%.
  • Over three fiscal years its annual growth of +15.2% compares with a peer median of +15.4%.
OWLT Competitors Peer median
Revenue for OWLT and competitors
Company Period LTM YoY 3-year CAGR
ANIKAnika Therapeutics, Inc.LTM Mar 2026$116.26M +23.2%-0.3%
OWLTOwlet, Inc.LTM Mar 2026$107.06M +26.8%+15.2%
LNSRLENSAR, Inc.LTM Mar 2026$57.7M +1.1%+18.2%
RPIDRapid Micro Biosystems, Inc.LTM Mar 2026$34.38M +16.0%+25.2%
MXCTMaxCyte, Inc.LTM Mar 2026$32.29M -14.3%-9.3%
LUCDLucid Diagnostics Inc.LTM Mar 2026$5.13M +23.0%+132.0%
AVRAnteris Technologies Global Corp.LTM Mar 2026$1.85M -25.7%-15.8%
CRDFCardiff Oncology, Inc.LTM Mar 2026$525K -10.7%+15.4%
CRBPCorbus Pharmaceuticals Holdings, Inc.LTM Mar 2026$0 ——
ELTXElicio Therapeutics, Inc.LTM Mar 2026$0 ——
Peer median (excluding OWLT) $5.13M+1.1%+15.4%

Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue75.84M69.2M54.01M78.06M105.71M
Cost of Revenue40.78M45.89M31.42M38.75M52.18M
Gross Profit35.06M23.31M22.59M39.31M53.53M
Gross Margin46.2%33.7%41.8%50.4%50.6%
Research & Development21.43M27.9M10.35M9.8M14.08M
Selling, General & Admin69.42M80.04M40.87M49.73M47.72M
Operating Expenses90.85M107.93M51.22M59.53M61.79M
Depreciation & Amortization1.13M2.67M2.21M1.38M590K
EBITDA(42.71M)(75.53M)(27.49M)(9.47M)(35.64M)
EBITDA Margin-56.3%-109.1%-50.9%-12.1%-33.7%
Operating Income(55.79M)(84.62M)(28.63M)(20.22M)(8.26M)
Operating Margin-73.6%-122.3%-53.0%-25.9%-7.8%
Interest Income00000
Interest Expense27.83M1.1M3.19M1.63M3.42M
Other Income / Expenses(15.88M)5.31M(4.26M)7.74M(31.39M)
Income Before Tax(71.67M)(79.31M)(32.89M)(12.48M)(39.65M)
Pre-Tax Margin-94.5%-114.6%-60.9%-16.0%-37.5%
Income Tax Expense31K29K10K54K28K
Net Income(71.7M)(79.34M)(32.9M)(12.54M)(39.68M)
Net Margin-94.5%-114.6%-60.9%-16.1%-37.5%
EPS (Basic)(12.47)(9.97)(4.53)(0.83)(2.24)
EPS (Diluted)(12.47)(9.97)(4.53)(0.83)(2.24)
Weighted Avg Shares7.87M7.95M8.28M15.11M562.5M
Weighted Avg Shares (Diluted)7.87M7.95M8.28M15.11M562.5M

Owlet, Inc.

NYSE:OWLT

Intrinsic Alpha fair value

Locked

Current Price

$3.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.